Skip to main content
Equibles

Stonepine Capital Management, LLC

Position in SPRB — Spruce Biosciences, Inc.

CIK 1440771 BEND, OR
Back to SPRB Full portfolio

Position in SPRB

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$1,554,930
-$164,795 QoQ
Shares Held
28,795
+45.9% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#20
of 63 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Stonepine Capital Management, LLC holds $108,574,607 across 61 Biotechnology names. SPRB ranks #18 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VSTM
Verastem, Inc.
 3,349,627 $12,795,575
2 TENX
Tenax Therapeutics, Inc.
 660,000 $9,603,000
3 NKTR
Nektar Therapeutics
 120,654 $8,422,855
4 ADMA
Adma Biologics, Inc.
 740,000 $6,193,800
5 CAMP
Camp4 Therapeutics Corp
 1,389,622 $6,072,648
6 ELOX
Eloxx Pharmaceuticals, Inc.
 397,160 $5,512,580
7 KZIA
Kazia Therapeutics Ltd
 345,179 $4,860,120
8 CRBP
Corbus Pharmaceuticals Holdings, Inc.
 425,000 $3,986,500

All Filings in SPRB

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,554,930 28,795
2025-12-31 $1,719,725 19,742